News from NORD

NCATS Unveils Toolkit for Patient-Focused Therapy Development

Publish date: August 7, 2018

 

The National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) has developed a new toolkit for the rare disease community to facilitate therapeutics research and development. Learn more about the toolkit here.

Recommended Reading

FDA approves Epidiolex for Lennox-Gastaut syndrome and Dravet syndrome
MDedge Family Medicine
Oral drug seen preventing angioedema attacks
MDedge Family Medicine
Study supports meningococcal B vaccine in children with rare diseases
MDedge Family Medicine
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Family Medicine
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Family Medicine
RFPs Available for the Study of Three Rare Diseases
MDedge Family Medicine
More Than 100 Patient Organizations Join NORD in Supporting the RARE Act
MDedge Family Medicine
Medical Nutrition Equity Act Capitol Hill Day Planned for June 1
MDedge Family Medicine
NORD and Other Patient Organizations Oppose Short-Term, Limited-Duration Health Plans
MDedge Family Medicine
Running for Rare Team Participates in Boston Marathon to Raise Funds for Undiagnosed Patients
MDedge Family Medicine